Show cover of BioBoss

BioBoss

BioBoss is a podcast about leadership in the biopharma community. Hear directly from the founders and CEOs of today's most innovative companies. Listen in as Wyant Simboli Principal and branding veteran John Simboli poses the questions "What drives you? How do you create change? Why should people care?" to biopharma leaders and hear insights on this rapidly developing field.

Tracks

#51 - Jesús Martin-Garcia: CEO of GeNeuro
Jesús Martin-Garcia, CEO of GeNeuro, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Geneuro is working to develop treatments against neurological disorders and autoimmune diseases by neutralizing causal factors encoded by Human Endogenous Retroviruses.
42:01 09/19/2022
#50 - Cliff Stocks: Founder and CEO, OncoResponse
Cliff Stocks, founder and CEO of OncoResponse speaks with BioBoss host John Simboli. Hear Cliff’s insights about leadership in biopharma and how OncoResponse is working to identify fully human monoclonal antibodies as therapeutics for the treatment of cancer.
34:25 08/17/2022
#49 - Brian Finrow: Co-founder & CEO, Lumen Bioscience
Brian Finrow, Co-founder and CEO of Lumen Bioscience, speaks with BioBoss host and biopharma branding veteran John Simboli. Hear Brian’s thoughts about leadership and how Lumen Biosciences is working to unlock the full potential of biologic drugs, whose promise has been held back by the lack of scalable technology. 
41:08 07/16/2022
#48 - Alex Blyth: Founder & CEO, LifT BioSciences
The show producer has not yet provided a description for this episode.
36:36 06/18/2022
#47 - Andrew Hall: CEO of IMV Inc.
The show producer has not yet provided a description for this episode.
30:23 05/21/2022
#46 - Kevin Lee: CEO of Bicycle Biotherapeutics
Kevin Lee, CEO of Bicycle Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Bicycle Therapeutics is working on developing a new class of medicines, called Bicycles, for diseases that are underserved by existing therapeutics. 
39:47 04/18/2022
#45 - Reenie McCarthy: CEO of Stealth BioTherapeutics
BioBoss host John Simboli speaks with Reenie McCarthy, CEO of Stealth BioTherapeutics, headquartered in Needham, MA.. Hear Reenie's thoughts about leadership in biopharma and how Stealth Biotherapeutics is working on developing therapies to treat the mitochondrial dysfunction associated with genetic mitochondrial diseases and many common age-related diseases.
27:05 03/26/2022
#44 - Yochi Slonim: Founder & CEO, Anima Biotech
BioBoss host John Simboli speaks with Yochi Slonim, founder and CEO of Anima Biotech, headquartered in Boston with R&D in Tel Aviv.. Hear Yochi's thoughts about leadership in biopharma and how Anima Biotech is working on a novel approach for the discovery of small molecules that selectively control mRNA translation as a new strategy against undruggable proteins.
40:43 02/05/2022
#43 - Clive Richardson: CEO of Akari Therapeutics
BioBoss host John Simboli speaks with Clive Richardson, CEO of Akari Therapeutics, headquartered in London with offices in New York. Hear Clive's thoughts about leadership in biopharma and how Akari Therapeutics  is working to develop life-transforming treatments for autoinflammatory diseases involving the complement and leukotriene  pathways
32:36 01/08/2022
Welcome to Season 4 of BioBoss
BioBoss podcast host John Simboli reflects on the success of seasons 1, 2 and 3 and welcomes listeners to listen in on his conversations about leadership with biopharma founders and CEOs in  BioBoss season 4.
01:20 12/28/2021
#42 - Stefan König: CEO of George Medicines
BioBoss host John Simboli speaks with Stefan König , CEO of George Medicines, headquartered in London. Hear Stefan’s thoughts about leadership in biopharma and how George Medicines is working to extend and improve the lives of people suffering from the world’s leading causes of death and disability—including hypertension, cardiovascular disease and type 2 diabetes
38:06 12/04/2021
#41 - Derek Maetzold: CEO of Castle Biosciences
Derek Maetzold, CEO of Castle Biosciences shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Castle is leveraging its expertise in cancer genomics and the use of artificial intelligence to improve patient outcomes.
38:12 10/29/2021
#40 - Bob Cobuzzi - CEO of Diffusion Pharmaceuticals
Bob Cobuzzi, Chief Executive Officer of Diffusion Pharmaceuticals,speaks with BioBoss John Simboli about leadership and how Diffusion Pharmaceuticals is working to develop novel therapies that enhance the body’s ability to deliver oxygen to the areas where it is needed most.
34:22 10/02/2021
#39 - Panna Sharma - CEO of Lantern Therapeutics
Panna Sharma, CEO of Lantern Pharma, headquartered in Dallas, Texas, shares his thoughts with BioBoss host John Simboli about leadership and how Lantern is working at the intersection of artificial intelligence, genomics and machine learning to advance precision oncology therapies.
38:38 09/12/2021
#38 - Nandan Padukone: CEO of IM Therapeutics
Nandan Padukone, CEO of IM Therapeutics, headquartered in Woburn, Massachusetts, shares his thoughts with BioBoss host John Simboli about leadership and how IM Therapeutics is targeting the root cause of autoimmunity with therapeutic design directed at human leukocyte antigens.
44:36 07/31/2021
#37 - Matthew Gline: CEO of Roivant Sciences
The show producer has not yet provided a description for this episode.
39:20 07/10/2021
#36 - Koen De Witte: Managing Director, ReMYND
Koen De Witte, managing director of reMYND NV, headquartered in Leuven, Belgium, shares his thoughts with BioBoss host John Simboli about leadership and how reMYND is advancing treatments for Alzheimer’s, diabetes and other diseases caused by cellular dysfunction. 
31:19 05/30/2021
#35 - Lanny Sun: Co-founder, Silicon Therapeutics
Lanny Sun, co-founder of Silicon Therapeutics, recently acquired by Roivant Sciences. speaks with corporate branding veteran John Simboli about leadership in biopharma. Lanny also discusses how Silicon Therapeutics, now part of Roivant Drug Discovery, is advancing its chip-to-clinic, computational quantum physics-based approach to pioneer a new path for drug design of  medicines to improve the lives of patients
36:43 05/01/2021
#34 - Joan Perelló: Co-Founder and CEO of Sanifit
Joan Perelló, co-founder and CEO of Sanifit, shares his thoughts with BioBoss host John Simboli about leadership and how Sanifit is pursuing the development of treatments for progressive vascular calcification disorders.
36:43 04/03/2021
#33 - Saiid Zarrabian: CEO of Kintara Therapeutics
Saiid Zarrabian, President and CEO of Kintara Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership and how Kintara is pursuing the development of new cancer therapies for patients with rare unmet medical needs.
27:15 03/13/2021
#32 - John Temperato: CEO of 9 Meters Biopharma
John Temperato, President and Chief Executive Officer of 9 Meters Biopharma, speaks with BioBoss host John Simboli about leadership in biopharma and how 9 Meters is advancing drug candidates for patients with rare and unmet gastrointestinal disorders including short bowel syndrome and celiac disease. 
32:05 02/07/2021
#31 - Shawn Singh: CEO of VistaGen Therapeutics
Shawn Singh, CEO of VistaGen, speaks with BioBoss host John Simboli about leadership and VistaGen's working to develop a new generation of medications for anxiety, depression and other central nervous system disorders.
39:58 01/10/2021
Welcome to Season 3 of BioBoss
BioBoss podcast host John Simboli reflects on the success of seasons 1 and 2 and welcomes listeners to listen in on his conversations about leadership with biopharma founders and CEOs in  BioBoss season 3.
01:08 01/06/2021
#30 - Bobby Gaspar: CEO of Orchard Therapeutics
Bobby Gaspar, founder and  CEO of Orchard Therapeutics, speaks with BioBoss host John Simboli about leadership and how Orchard Therapeutics is pursuing the opportunity to change medicine and change the lives of people with severe genetic diseases. 
40:09 12/08/2020
#29 - Itamar Kandel: CEO of HeartVista
Itamar Kandel, CEO of HeartVista, speaks with BioBoss host John Simboli about leadership and how HeartVista leverages machine learning to simplify diagnostic imaging and help physicians more accurately diagnose cardiovascular disease.
37:14 11/08/2020
#28 - Mark Altmeyer: Founder and CEO of Arvelle Therapeutics
Mark Altmeyer, founder and CEO of Arvelle Therapeutics, speaks with BioBoss host John Simboli. Hear Mark’s thoughts about leadership and how Arvelle is working to bring new solutions to people living with epilepsy and CNS disorders.
33:37 10/17/2020
#27 - Jacob Becraft: Co-Founder & CEO, Strand Therapeutics
Jacob Becraft, co-founder & CEO of Strand Therapeutics shares his thoughts with BioBoss host John Simboli about leadership and how Strand is working in synthetic biology and messenger RNA to target root causes of genetic disease, with the power to control editing at a single-cell level.
44:52 09/26/2020
#26 - Eran Eden: Co-Founder and CEO of MeMed
Eran Eden, co-founder and CEO of MeMed, shares his thoughts on leadership and how MeMed is working to translate signals from the immune system into diagnostic insights to treat infectious disease and inflammatory disorders. 
44:04 09/15/2020
#25 - Nikolaj Sørensen: CEO of Orexo
Nikolaj Sørensen, CEO of Orexo Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership and, digital and bio-therapeutics, how the coronavirus is changing the landscape around mental health, depression, substance abuse and addiction,
37:37 08/29/2020
#24 - Per Hellsund: Co-Founder and CEO of Cybrexa
Per Hellsund, co-founder and CEO of Cybrexa Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership, building a culture of transparency, and Cybrexa's advances in treating the cancer tumor microenvironment.
35:42 07/25/2020